PrOXisense Analysis: $7M Raised
What is PrOXisense?
PrOXisense develops novel thermal analysis sensors for monitoring high-value machinery in aerospace and chemical processes. Technologies operate in extreme environments and support in vivo medical diagnostics through NHS clinical trials. The company has demonstrated sensor technology in Channel 4's counterfeit drug documentary.
Location
Farnborough, United Kingdom
Employees
1-10
Founded
2016
Funding Status
Seed
Product Features & Capabilities
- Thermal analysis sensors for engine air and oil condition monitoring
- Probes for metal debris quantification in fuels and oils
- High-frequency temperature and pressure sensors
- In vivo skin lesion sensors for medical diagnostics
- PAT sensors for pharmaceutical process monitoring
Use Cases
Monitor coolant quality in aerospace engines; Quantify metal debris in aviation fuels; Detect bearing wear in high-performance engines; Track pipeline erosion in chemical processes; Assess skin lesions in live patients via NHS clinical trial; Enable real-time process control in pharmaceutical manufacturing
Other Considerations
Demonstrated in Channel 4 counterfeit drug documentary; NHS clinical trial for in vivo skin lesion assessment; Validated mid-TRL probes for next-gen turbofan jets; Partnerships with aviation and defense sectors; Developed in Oxford University technology startup ecosystem
See something that needs updating? Suggest edits to this profile.